On ECHEMI
Home > Drugs > Puerarin Sodium Chloride Injection

Puerarin Sodium Chloride Injection

Function and Efficacy

This product is a vasodilator that can dilate coronary arteries and cerebral blood vessels, reduce myocardial oxygen consumption, improve microcirculation, and resist platelet aggregation.

Ingredients

The main component is 41,7-dihydroxy-8-beta;-D-glucosyl isoflavone with molecular formula C21H20O9 and molecular weight 416.4.

Indication

Used for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, and sudden deafness.

Usage and Dosage

Intravenous drip: 400-600 mg (in terms of puerarin) once a day, 15 days as a course of treatment.

Adverse Reactions

In some cases, there are temporary digestive tract reactions such as abdominal distension and nausea at the beginning of medication, which disappear on their own with continued medication. Allergic rashes are occasionally seen, which disappear on their own after stopping the medication.

Precautions

It is contraindicated for those who are allergic to the ingredients of this product.

Storage

Keep in a light-proof and airtight container.

Packaging Specification

100ml: Puerarin 0.2g and sodium chloride 0.9g

Manufacturer

Shanghai Huayuan Pharmaceutical (Ningxia) Shasai Pharmaceutical Co., Ltd.

  • Founded in:

    1994-07-29
  • Address:

    No. 6 Road, High-tech Development Zone, Yinchuan City, Ningxia
  • Tax NO.:

    91641100227756822X
  • Registered Funds:

    13.6 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.